CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

Abstract Background Combinatorial immunotherapy strategies for enhancing the responsiveness of immune system have shown great promise for cancer therapy. Engineered nanoformulation incorporated toll-like receptor (TLR) 9 agonist CpG ODN has shown more positive results in suppressing tumor growth and...

Полное описание

Библиографические подробности

Главные авторы:	Xiaofei Zhang, Qin Hu, Xuesong He, Xinyue Cui, Zhaoyuan Liang, Li Wang, Xiongwei Deng, Ze Zhang, Wang Sheng, Xiaodong D. Han
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2023-05-01
Серии:	Journal of Nanobiotechnology
Предметы:	Vaccine CpG ODN Neoantigen CD16 Immunotherapy
Online-ссылка:	https://doi.org/10.1186/s12951-023-01900-8
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!